Glargine | JP | Pharmacopoeia | Reference Standards| PharmaCompass.com

Please Wait

Applying Filters...

Glargine
JP

Glargine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 2 USDMF, 1 JDMF, 1 EU WC, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

68 FDF Dossiers, 10 FDA Orange Book, 34 Europe, 9 Canada, 4 Australia, 10 South Africa, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BASF, 1 Kerry, 1 Pluviaendo, 2 Seppic

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 4 Solubilizers, 3 Topical, 2 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Controlled & Modified Release, 1 Thickeners and Stabilizers, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives

DIGITAL CONTENT

16 DATA COMPILATION #PharmaFlow, 237 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 22 Finished Drug Prices, 31 Annual Reports

MARKET PLACE

7 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 3 JP, 2 Others

$ Xls

Filters

Filters

FILTER :

filter Reference Standard Reset all filters

3 All

01 3Insulin Glargine

filter Monograph in Japanese Pharmacopoeia Reset all filters

Product Main Page

01

Japanese Pharmacopoeia

Japan

2024 ACI Convention

Not Confirmed

02

Japanese Pharmacopoeia

Japan

2024 ACI Convention

Not Confirmed

03

Japanese Pharmacopoeia

Japan

2024 ACI Convention

Not Confirmed

Contact us
to update this info